Mark A Kane
Overview
Explore the profile of Mark A Kane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kane M
Int J Gynaecol Obstet
. 2018 Apr;
94 Suppl 1:S89-S94.
PMID: 29644645
The development and demonstration of the safety and effectiveness of new HPV vaccines is a major breakthrough in medical science that could prevent most cases of cervical cancer, the first...
2.
Kane M, Roudot-Thoraval F, Guerin N, Papaevangelou V, Van Damme P
Hum Vaccin Immunother
. 2016 Jun;
12(8):2053-2056.
PMID: 27261211
Control of hepatitis B through routine infant immunization in more than 95% of countries has reduced the prevalence of chronic hepatitis carriers to less than 1%-2% in immunized cohorts of...
3.
Bosch F, Broker T, Forman D, Moscicki A, Gillison M, Doorbar J, et al.
Vaccine
. 2013 Dec;
31 Suppl 7:H1-31.
PMID: 24332295
Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a...
4.
Bosch F, Broker T, Forman D, Moscicki A, Gillison M, Doorbar J, et al.
Vaccine
. 2013 Dec;
31 Suppl 6:G1-31.
PMID: 24331817
Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a...
5.
Bosch F, Broker T, Forman D, Moscicki A, Gillison M, Doorbar J, et al.
Vaccine
. 2013 Dec;
31 Suppl 5:F1-31.
PMID: 24331745
Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a...
6.
Bosch F, Broker T, Forman D, Moscicki A, Gillison M, Doorbar J, et al.
Vaccine
. 2013 Nov;
31 Suppl 8:I1-31.
PMID: 24229716
Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a...
7.
Kane M, Serrano B, de Sanjose S, Wittet S
Vaccine
. 2012 Dec;
30 Suppl 5:F192-200.
PMID: 23199963
Cervical cancer is the second leading cause of cancer death in women in less developed regions of the world and the leading cause of cancer deaths in GAVI-eligible countries, where...
8.
Bosch F, Tsu V, Vorsters A, Van Damme P, Kane M
Vaccine
. 2012 Dec;
30 Suppl 5:F1-11.
PMID: 23199951
The reframed paradigm of cervical cancer prevention will include strategic combinations of at least four major components: 1) routine introduction of human papillomavirus (HPV) vaccines to women in all countries,...
9.
Kane M
Cancer Prev Res (Phila)
. 2012 Jan;
5(1):24-9.
PMID: 22219163
The cancer control community is largely unaware of great advances in the control of major human cancers with vaccines, including the dramatic control of hepatocellular (liver) cancer with hepatitis B...
10.
Heffernan M, Garland S, Kane M
Sex Health
. 2010 Aug;
7(3):383-90.
PMID: 20719231
Background: Worldwide, prophylactic vaccines against two major human cancers are now commercially available: hepatitis B virus (HBV) vaccines (first licensed in 1982) against primary hepatocellular carcinoma and human papillomavirus (HPV)...